Skip to main content

JOHNSON & JOHNSON

corporate_fare Company Profile

JOHNSON & JOHNSON

JNJ·NYSE·Life Sciences·CIK 0000200406

Johnson & Johnson is a global healthcare company with approximately 138,200 employees worldwide. The company focuses on the research, development, manufacturing, and sale of a wide range of products primarily related to human health and well-being. Incorporated in New Jersey in 1887, Johnson & Johnson operates through its subsidiaries in virtually all countries globally. The company is structured into two main business segments: Innovative Medicine and MedTech. The Innovative Medicine segment concentrates on several therapeutic areas. These include Oncology, addressing conditions such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer. In Immunology, the focus is on rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis. Neuroscience covers mood disorders, neurodegenerative disorders, and schizophrenia. The segment also addresses Pulmonary Hypertension, specifically Pulmonary Arterial Hypertension, and Infectious Diseases like HIV/AIDS. Additionally, it covers Cardiovascular and Metabolism, including thrombosis, diabetes, and macular degeneration. Products within the Innovative Medicine segment are distributed for prescription use directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals.

JOHNSON & JOHNSON (NYSE:JNJ) is a publicly traded company in the Life Sciences sector. Wiseek monitors JNJ SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • J&J Commits $1 Billion to Expand Vision Operations in Florida
  • J&J's Talvey-Darzalex Combo Outperforms Standard of Care in Myeloma, Submits for FDA/EMA Expansion
  • J&J Expands US Rollout of TECNIS PureSee IOL for Cataract Surgery
  • J&J to Acquire Firefly Bio, Expanding Oncology Pipeline with Novel Degrader Antibody Conjugate Platform
  • J&J Prevails in Talc Lawsuit, Jury Finds No Negligence in Cancer Claims

Financial Snapshot

Fiscal year ended December 28, 2025
Revenue
$94.19B
Net Income
$26.8B
Diluted EPS
$11.03
Op. Cash Flow
$24.53B
Free Cash Flow
$19.7B
Gross Profit
$63.94B
Cash & Equivalents
$19.71B
Total Debt
$41.44B
Debt / Equity
0.51×
Net Margin
28.5%
Shares Outstanding
2.41B sh
Source: 10-K · filed 2026-02-11 · accession 0000200406-26-000016
Browse all tickers starting with J →
$234.16 -0.04% today
52-week range · as of 2026-04-22 $146.12 – $251.71
Market cap
$563.77B
Volume
8.5M (1.1× avg)
3-mo avg 7.7M
Live data · 2026-06-18 05:27 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed JNJ - Latest Insights

JNJ
Jun 15, 2026, 6:29 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $239.00
Real-time Price: $234.16 info
Change: -$4.84 (-2%) info
Market Cap: $563.77B info
JNJ
Jun 13, 2026, 6:39 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $240.01
Real-time Price: $234.16 info
Change: -$5.85 (-2%) info
Market Cap: $563.77B info
JNJ
Jun 11, 2026, 9:54 AM EDT
Source: BayStreet
Importance Score:
7
Price at Filing: $240.87
Real-time Price: $234.16 info
Change: -$6.71 (-3%) info
Market Cap: $563.77B info
JNJ
Jun 08, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $232.10
Real-time Price: $234.16 info
Change: +$2.06 (+0.89%) info
Market Cap: $563.77B info
JNJ
Jun 05, 2026, 6:20 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $232.00
Real-time Price: $234.16 info
Change: +$2.16 (+0.93%) info
Market Cap: $563.77B info
JNJ
May 31, 2026, 8:00 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $225.46
Real-time Price: $234.16 info
Change: +$8.70 (+4%) info
Market Cap: $563.77B info
JNJ
May 29, 2026, 9:35 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $230.78
Real-time Price: $234.16 info
Change: +$3.38 (+1%) info
Market Cap: $563.77B info
JNJ
May 28, 2026, 7:10 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $231.00
Real-time Price: $234.16 info
Change: +$3.16 (+1%) info
Market Cap: $563.77B info
JNJ
May 22, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $231.68
Real-time Price: $234.16 info
Change: +$2.48 (+1%) info
Market Cap: $563.77B info
JNJ
May 18, 2026, 9:35 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $226.23
Real-time Price: $234.16 info
Change: +$7.93 (+4%) info
Market Cap: $563.77B info
JNJ
May 04, 2026, 8:12 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $226.49
Real-time Price: $234.16 info
Change: +$7.67 (+3%) info
Market Cap: $563.77B info
JNJ
Apr 27, 2026, 8:44 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $227.11
Real-time Price: $234.16 info
Change: +$7.05 (+3%) info
Market Cap: $563.77B info
JNJ
Apr 24, 2026, 9:12 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $229.00
Real-time Price: $234.16 info
Change: +$5.16 (+2%) info
Market Cap: $563.77B info
JNJ
Apr 22, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $225.62
Real-time Price: $234.16 info
Change: +$8.54 (+4%) info
Market Cap: $563.77B info
JNJ
Apr 22, 2026, 10:40 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $226.29
Real-time Price: $234.16 info
Change: +$7.87 (+3%) info
Market Cap: $563.77B info
JNJ
Apr 17, 2026, 6:47 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $233.50
Real-time Price: $234.16 info
Change: +$0.660 (+0.28%) info
Market Cap: $563.77B info
JNJ
Apr 14, 2026, 4:07 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $240.10
Real-time Price: $234.16 info
Change: -$5.94 (-2%) info
Market Cap: $563.77B info
JNJ
Apr 14, 2026, 7:35 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $236.36
Real-time Price: $234.16 info
Change: -$2.20 (-0.93%) info
Market Cap: $563.77B info
JNJ
Apr 14, 2026, 6:20 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $236.42
Real-time Price: $234.16 info
Change: -$2.26 (-0.96%) info
Market Cap: $563.77B info
JNJ
Apr 13, 2026, 12:44 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $235.52
Real-time Price: $234.16 info
Change: -$1.36 (-0.58%) info
Market Cap: $563.77B info